FOLH1 and posterior cortical atrophy: With the advent of newly imaging technology prostate-specific membrane antigen (PSMA) PET/CT has significantly increased the detection rate of extra-pelvic metastases of PCa, providing more clinical reference for the treatment of oligo-metastasis disease (6–8).